Login / Signup

Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series.

Maahum MehdiAniko SzaboAditya ShreenivasJames P ThomasSusan TsaiKathleen K ChristiansDouglas B EvansCallisia N ClarkeWilliam A HallBeth EricksonGulrayz AhmedBicky ThapaThomas McFallBen GeorgeRazelle KurzrockMandana Kamgar
Published in: Therapeutic advances in medical oncology (2024)
PDAC treated with chemotherapy-free matched targeted agents. Prospective studies are warranted.
Keyphrases
  • wild type
  • cancer therapy
  • locally advanced
  • drug delivery
  • chemotherapy induced
  • combination therapy
  • newly diagnosed